CAS: 180288-69-1 - Trastuzumab
- Synonyme:
- Trastuzumab [USAN:INN]
- Herceptin
- Immunoglobulin G 1 (human-mouse monoclonal rhuMab HER2gamma1-chain antihuman p185(sup c-erbB2) receptor), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
- Unii-P188Anx8Ck
- Immunoglobulin G1, anti-(human p185neu receptor) (human-mouse monoclonal rhuMab HER2 gamma1-chain), disulfide with human-mouse monoclonal rhuMab HER2 light chain, dimer
| Marke | Produktdaten | Reinheit | Preisklasse | Voraussichtliche Lieferung |
|---|---|---|---|---|
 | Trastuzumab REF: TM-T9912CAS: 180288-69-1 | 98% - 99.50% | 152,00 €~1.831,00 € | Di 10 Dez 24 |
 | Trastuzumab - 20mg/ml in PBS REF: 3D-FT65040CAS: 180288-69-1 | Min. 95 Area-% | 237,00 €~1.547,00 € | Mi 11 Dez 24 |
Trastuzumab
CAS:180288-69-1
Trastuzumab is a humanized monoclonal antibody for patients with invasive breast cancers that overexpress HER2.
Reinheit:
98% - 99.50%
Farbe und Form:
Solid
Molekulargewicht:
Approximately 145.53 kDa
- Inhibitoren
- EGFR
- Tyrosinkinase/Adaptoren
- PI3K/Akt/mTOR-Signalgebung
- Mehr Kategorien anzeigen
- Trastuzumab und Verunreinigungen
Ref: TM-T9912
| 1mg | 152,00 € | ||
| 5mg | 511,00 € | ||
| 10mg | 640,00 € | ||
| 25mg | 1.009,00 € | ||
| 50mg | 1.364,00 € | ||
| 100mg | 1.831,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Dienstag 10. Dezember 2024
Trastuzumab - 20mg/ml in PBS
CAS:180288-69-1
Monoclonal antibody against HER2 for breast cancer treatment
Reinheit:
Min. 95 Area-%
Farbe und Form:
Clear Liquid
Ref: 3D-FT65040
| 1mg | 237,00 € | ||
| 10mg | 801,00 € | ||
| 25mg | 1.547,00 € |
Voraussichtliche Lieferung in Vereinigte Staaten, am Mittwoch 11. Dezember 2024
